5 Stocks Winning 52-Week Highs as DJIA and S&P Decline 1% Today Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Get the most recent company news and stock data here >> Eli ... |
